Mast cells can revert dexamethasone-mediated down-regulation of stem cell factor
- 22 February 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 414 (1) , 105-112
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mast‐cell growth and differentiationAllergy, 1999
- Glucocorticoid signalling—multiple variations of a common themeMolecular and Cellular Endocrinology, 1998
- Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems.Journal of Clinical Investigation, 1997
- Retinoic acids and dexamethasone alter cell-surface density of β2-integrins and ICAM-1 on human leukemic (HMC-1) mast cellsArchives of Dermatological Research, 1997
- Intermediate filament proteins in TPA-treated skeletal muscle cells in cultureJournal of Muscle Research and Cell Motility, 1996
- Mast cells are potent regulators of endothelial cell adhesion molecule ICAM‐1 and VCAM‐1 expressionJournal of Cellular Physiology, 1995
- Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutantCell, 1991
- Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.Journal of Experimental Medicine, 1991
- Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen‐induced weal‐and‐flare response and a reduction in skin mast cell numbers and histamine contentClinical & Experimental Allergy, 1989
- Comparison of three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebratesJournal of Molecular Evolution, 1986